- €555.19m
- €494.88m
- €896.45m
- 77
- 44
- 89
- 84
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 507 | 592 | 690 | 680 | 896 |
Cost of Revenue | |||||
Gross Profit | 187 | 244 | 318 | 310 | 355 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 468 | 538 | 660 | 661 | 852 |
Operating Profit | 38.6 | 54.4 | 30 | 19 | 44.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 36.9 | 44.3 | 23.4 | 13 | 42.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27.2 | 34.6 | 10.7 | 1.05 | 24.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 15.4 | 26.9 | 12.7 | -11.6 | 11.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15.4 | 26.9 | 12.7 | -11.6 | 11.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.33 | 2.72 | 2.42 | 0.594 | 2.03 |
Dividends per Share | |||||
Special Dividends per Share |